![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:620578 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SH3GL3 mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1551861 | 6480464 | Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of SH3GL3 mRNA] | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of SH3GL3 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:620578 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SH3GL3 mRNA | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620578 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SH3GL3 mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | RGD:620578 | 6480464 | 2 more ... | CTD | PMID:32109520 | 2,6-dinitrotoluene | affects expression | ISO | RGD:620578 | 6480464 | 2, 6-dinitrotoluene affects the expression of SH3GL3 mRNA | CTD | PMID:21346803 | 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:620578 | 6480464 | 1, 2-dithiol-3-thione results in decreased expression of SH3GL3 mRNA | CTD | PMID:19162173 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1551861 | 6480464 | Fenretinide results in increased expression of SH3GL3 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | ISO | RGD:620578 | 6480464 | Propylthiouracil results in increased expression of SH3GL3 mRNA | CTD | PMID:24780913 | acetamide | decreases expression | ISO | RGD:620578 | 6480464 | acetamide results in decreased expression of SH3GL3 mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | increases expression | ISO | RGD:620578 | 6480464 | Tretinoin results in increased expression of SH3GL3 mRNA | CTD | PMID:20488242 | amiodarone | affects expression | ISO | RGD:620578 | 6480464 | Amiodarone affects the expression of SH3GL3 mRNA | CTD | PMID:18355885 | amitriptyline | affects expression | ISO | RGD:620578 | 6480464 | Amitriptyline affects the expression of SH3GL3 mRNA | CTD | PMID:18355885 | ammonium chloride | affects expression | ISO | RGD:620578 | 6480464 | Ammonium Chloride affects the expression of SH3GL3 mRNA | CTD | PMID:16483693 | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SH3GL3 mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SH3GL3 mRNA | CTD | PMID:32525701 | arsenite(3-) | increases expression | ISO | RGD:1551861 | 6480464 | arsenite results in increased expression of SH3GL3 mRNA | CTD | PMID:18929588 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzoapyrene results in decreased methylation of SH3GL3 promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:620578 | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3GL3 mRNA | CTD | PMID:31199487 | bisphenol A | decreases expression | ISO | RGD:620578 | 6480464 | bisphenol A results in decreased expression of SH3GL3 mRNA | CTD | PMID:25181051, PMID:30816183 | bisphenol A | increases methylation | ISO | RGD:620578 | 6480464 | bisphenol A results in increased methylation of SH3GL3 gene | CTD | PMID:28505145 | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of SH3GL3 mRNA | CTD | PMID:26079696 | Butylbenzyl phthalate | multiple interactions | ISO | RGD:620578 | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3GL3 mRNA | CTD | PMID:31199487 | C60 fullerene | decreases expression | ISO | RGD:620578 | 6480464 | fullerene C60 results in decreased expression of SH3GL3 mRNA | CTD | PMID:19167457 | cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of SH3GL3 mRNA | CTD | PMID:24376830 | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of SH3GL3 mRNA | CTD | PMID:16002434 | clofibrate | multiple interactions | ISO | RGD:1551861 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SH3GL3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SH3GL3 mRNA] | CTD | PMID:17585979 | clomipramine | affects expression | ISO | RGD:620578 | 6480464 | Clomipramine affects the expression of SH3GL3 mRNA | CTD | PMID:18355885 | dibenz[a,h]anthracene | increases expression | ISO | RGD:1551861 | 6480464 | 1 more ... | CTD | PMID:26377693 | dibutyl phthalate | increases expression | ISO | RGD:1551861 | 6480464 | Dibutyl Phthalate results in increased expression of SH3GL3 mRNA | CTD | PMID:21266533 | dibutyl phthalate | multiple interactions | ISO | RGD:620578 | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3GL3 mRNA | CTD | PMID:31199487 | dibutyl phthalate | decreases expression | ISO | RGD:620578 | 6480464 | Dibutyl Phthalate results in decreased expression of SH3GL3 mRNA | CTD | PMID:21266533 | diethyl phthalate | multiple interactions | ISO | RGD:620578 | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3GL3 mRNA | CTD | PMID:31199487 | diethylstilbestrol | increases expression | ISO | RGD:1551861 | 6480464 | Diethylstilbestrol results in increased expression of SH3GL3 mRNA | CTD | PMID:16636312 | diisobutyl phthalate | multiple interactions | ISO | RGD:620578 | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3GL3 mRNA | CTD | PMID:31199487 | diisononyl phthalate | multiple interactions | ISO | RGD:620578 | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3GL3 mRNA | CTD | PMID:31199487 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SH3GL3 mRNA | CTD | PMID:27188386 | endosulfan | affects expression | ISO | RGD:620578 | 6480464 | Endosulfan affects the expression of SH3GL3 mRNA | CTD | PMID:29391264 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of SH3GL3 mRNA | CTD | PMID:27188386 | ethanol | affects expression | ISO | RGD:1551861 | 6480464 | Ethanol affects the expression of SH3GL3 mRNA | CTD | PMID:30319688 | flutamide | increases expression | ISO | RGD:620578 | 6480464 | Flutamide results in increased expression of SH3GL3 mRNA | CTD | PMID:24793618 | folic acid | multiple interactions | ISO | RGD:1551861 | 6480464 | Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of SH3GL3 mRNA] | CTD | PMID:22206623 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of SH3GL3 mRNA | CTD | PMID:23649840 | imipramine | affects expression | ISO | RGD:620578 | 6480464 | Imipramine affects the expression of SH3GL3 mRNA | CTD | PMID:18355885 | ketoconazole | affects expression | ISO | RGD:620578 | 6480464 | Ketoconazole affects the expression of SH3GL3 mRNA | CTD | PMID:18355885 | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of SH3GL3 mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | EXP | | 6480464 | Lead affects the expression of SH3GL3 mRNA | CTD | PMID:28903495 | paracetamol | multiple interactions | ISO | RGD:1551861 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SH3GL3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SH3GL3 mRNA] | CTD | PMID:17585979 | perfluorooctanoic acid | decreases expression | ISO | RGD:620578 | 6480464 | perfluorooctanoic acid results in decreased expression of SH3GL3 mRNA | CTD | PMID:19162173 | phenobarbital | decreases expression | ISO | RGD:620578 | 6480464 | Phenobarbital results in decreased expression of SH3GL3 mRNA | CTD | PMID:19162173 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SH3GL3 mRNA | CTD | PMID:27188386 | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SH3GL3 mRNA | CTD | PMID:32525701 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of SH3GL3 mRNA | CTD | PMID:31533062 | tetrachloromethane | multiple interactions | ISO | RGD:620578 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SH3GL3 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | RGD:620578 | 6480464 | Carbon Tetrachloride results in decreased expression of SH3GL3 mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | ISO | RGD:620578 | 6480464 | Thioacetamide results in decreased expression of SH3GL3 mRNA | CTD | PMID:23411599 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of SH3GL3 mRNA | CTD | PMID:24935251 | trimellitic anhydride | decreases expression | ISO | RGD:1551861 | 6480464 | trimellitic anhydride results in decreased expression of SH3GL3 mRNA | CTD | PMID:19042947 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SH3GL3 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SH3GL3 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SH3GL3 mRNA | CTD | PMID:23179753 more ... | vinclozolin | decreases expression | ISO | RGD:620578 | 6480464 | vinclozolin results in decreased expression of SH3GL3 mRNA | CTD | PMID:23034163 | |